David Apelian

Chief Executive Officer at

Theolytics Ltd.

61 year

Health Technology

Consumer Services

Profile

David Apelian is currently Chief Executive Officer at Theolytics Ltd. since 2024.
Formerly, Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. from 2022 to 2024, Chief Executive Officer & Director at BlueSphere Bio, Inc. from 2019 to 2022, Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. from 2013 to 2017, Chief Medical Officer, SVP-Research & Development at GlobeImmune, Inc. from 2008 to 2013, Clinical Director-Infectious Diseases Group at Bristol Myers Squibb Co. from 2002 to 2004, Clinical Director-Hepatology Department at Schering-Plough Corp.
from 1999 to 2002, and Vice President at Wyeth Pharmaceuticals LLC.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey, undergraduate and doctorate degrees from Rutgers State University of New Jersey, and an MBA from Quinnipiac University.

David Apelian active positions

Companies	Position	Start
Theolytics Ltd. Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology	Chief Executive Officer	17/12/2024

All active positions of David Apelian

Former positions of David Apelian

Companies	Position	End
EIGER BIOPHARMACEUTICALS	Chief Executive Officer	01/09/2024
BlueSphere Bio, Inc. BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs products	Chief Executive Officer	04/10/2022
ACHILLION PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	28/12/2017
GLOBEIMMUNE, INC.	Chief Tech/Sci/R&D Officer	01/01/2013
BRISTOL-MYERS SQUIBB COMPANY	Chief Tech/Sci/R&D Officer	-

See the detail of David Apelian's experience

Training of David Apelian

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Apelian's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Schering-Plough Corp. Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products	Health Technology
Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases	Health Technology
GlobeImmune, Inc. GlobeImmune, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic products for cancer and infectious diseases	Health Technology
Wyeth Pharmaceuticals LLC Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products	Health Technology
University of Medicine & Dentistry of New Jersey University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Quinnipiac University Quinnipiac University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases	Health Technology
Theolytics Ltd. Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology	Health Technology
BlueSphere Bio, Inc. BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs products	Health Technology